Similarly, in POLARSTAR study elderly Japanese patients with previously treated NSCLC, not selected for EGFR mutations, showed a trend toward a longer PFS in comparison to younger group, even if not statistically significant.[15]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.